UBE2T and cancer: A series of studies have shown that UBE2T is overexpressed as an oncogene in various types of cancer, including hepatocellular carcinoma, lung adenocarcinoma, pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, and glioblastoma (Figure 5).